Exposure to Plasticisers in the Neonatal Intensive Care Unit
NCT05404815
Behavior, Bronchopulmonary Dysplasia
Edegem, Antwerp, Belgium
View Trial DetailsNCT Number: NCT02820818
Preterm birth alters the normal sequence of lung development with lasting respiratory consequences. It is still unclear whether observed respiratory morbidities in preterm born individuals reflect sequelae from a non-progressive lung disease that occurred early in life or result from ongoing active disease that, if left undiagnosed and untreated, could increase the risk of a COPD-like phenotype. We propose to examine micro-structural abnormalities of the lung using innovative non-invasive imaging technologies in relation to pulmonary function and markers of inflammation and oxidative stress in young adults born preterm.
Looking for future studies?
Notify Me20 year–29 year
All sexes
Observational
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline
Pulmonary hydrogen protons (1H) magnetic resonance imaging (MRI) using ultra-short echo time pulse sequences will be performed to quantify signal intensity (SI) as a surrogate of parenchymal tissue density.
Time frame: Baseline
Thoracic hyperpolarized 129Xe MRI to measure apparent diffusion coefficient (ADC) - subgroup of 10 participants (5 preterm, 5 control)
Time frame: Baseline
Spirometry (FEV1/FVC) will be performed according to the American Thoracic Society guidelines
Time frame: Baseline
Lung volumes (RV/TLC) by plethysmography will be performed according to the American Thoracic Society guidelines
Time frame: Baseline
DLCO will be performed according to the American Thoracic Society guidelines
Time frame: Baseline
Lung clearance index by nitrogen washout will be performed according to the American Thoracic Society guidelines
Time frame: Baseline
Oxidative stress markers glutathione (GSH, GSSG; by capillary zone Electrophoresis) with calculation of Redox potential by the Nernst equation
Time frame: Baseline
Surfactant protein D (plasma)
Time frame: Baseline
CCSP-16 (plasma)
St. Justine's Hospital
Other
Bronchopulmonary Dysplasia: From Neonatal Chronic Lung Disease to Early Onset Adult COPD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05404815
Behavior, Bronchopulmonary Dysplasia
Edegem, Antwerp, Belgium
View Trial DetailsNCT03649932
Bronchopulmonary Dysplasia, Bronchopulmonary Dysplasia Associated Pulmonary Hypertension
Galveston, Texas, United States
View Trial DetailsNCT00422305
Asthma, Bronchial Diseases
Indianapolis, Indiana, United States
View Trial DetailsNCT00233324
Bronchopulmonary Dysplasia, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Birmingham, Alabama, United States
View Trial Details